O'Rourke & Company’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.18M | Sell |
1,514
-48
| -3% | -$37.4K | 0.55% | 45 |
|
|
2025
Q1 | $1.29M | Buy |
1,562
+83
| +6% | +$68.6K | 0.64% | 35 |
|
|
2024
Q4 | $1.14M | Buy |
1,479
+27
| +2% | +$20.8K | 0.56% | 39 |
|
|
2024
Q3 | $1.29M | Buy |
1,452
+340
| +31% | +$301K | 0.64% | 36 |
|
|
2024
Q2 | $1.01M | Buy |
1,112
+29
| +3% | +$26.3K | 0.57% | 39 |
|
|
2024
Q1 | $843K | Buy |
1,083
+256
| +31% | +$199K | 0.49% | 48 |
|
|
2023
Q4 | $482K | Buy |
827
+340
| +70% | +$198K | 0.31% | 65 |
|
|
2023
Q3 | $262K | Hold |
487
| – | – | 0.19% | 107 |
|
|
2023
Q2 | $228K | Buy |
+487
| New | +$228K | 0.16% | 125 |
|
|
2023
Q1 | – | Sell |
-787
| Closed | -$288K | – | 133 |
|
|
2022
Q4 | $288K | Buy |
+787
| New | +$288K | 0.23% | 101 |
|